Europe

News

Adult vaccination programmes deliver socio-economic benefits up to 19 times initial investment, according to new report

18 April 2024

Our new report examines the promise of prevention in healthcare and provides six key recommendations that could usher in a new era of optimised prevention.

Insights

Plan For A New EU Pharmaceutical Legislation: What Will It Mean For Pharmaceutical Innovation?

12 April 2024

The European Commission and European Parliament have set out their proposals for a reformed EU pharmaceutical legislation which could substantially change the incentive ecosystem for the first time in 20 years.

Insights

Breaking the European Deadlock: Part 3 – Revenue Guarantee and Subscription Models for New Antibiotics

16 January 2024

Insight 3 of this series provides an exploration of revenue guarantee/subscription models and how they could be implemented in the EU.

Breaking the European Deadlock: Part 2 - Transferable Exclusivity Vouchers – Effective Pull Incentive or a Policy Distraction?
Insights

Breaking the European Deadlock: Part 2 – Transferable Exclusivity Vouchers – Effective Pull Incentive or a Policy Distraction?

4 January 2024

This is part 2 of the insight series which explores how progress towards an effective pull incentive for antibiotics can be made in Europe.

Slovak Republic
Insights

Around The World in HTAs: The Slovak Republic – Valuing the Future

13 September 2023

In this Insights series, Around the World in HTAs, we shed light on HTA around the world. In this edition, Patricia Cubi-Molla & Jake Hitch, OHE, and Róbert Babeľa, Slovak Medical University, take us to the Slovak Republic.

Learnings from the Assessments of Entrectinib and Larotrectinib: Health Technology Assessment Challenges Associated with Tumour-Agnostic Therapies
Insights

Combination Therapies: A Step Forward to the Value Attribution Problem

4 January 2023

OHE convened a roundtable discussion to present and discuss recent work by OHE colleagues and collaborators on value attribution frameworks for combination therapies.

Cracks through the ice on a melting glacier in Alaska
Insights

Does Government Funding Increase Public Sector Development of New Medicines?

5 March 2021

A new paper, published last week in Applied Economics, by Dimitrios Kourouklis, Senior Economist at OHE, looks at the question of whether government funding increases public…

Key Factors on How to Procure, Pay and use Vaccines for COVID-19 2-01
Publication

Key Factors on How to Procure, Pay, Distribute and Use Vaccines for COVID-19: A European Perspective

1 May 2021

After the shock caused by the first wave of COVID-19, discovering vaccines against the virus and administering them quickly to the population became the utmost priority…

Opportunities to Increase Efficiency in Healthcare
Publication

Opportunities to Increase Efficiency in Healthcare

1 October 2020

Substantial economic resources are devoted to healthcare across Europe, but there is evidence that a large proportion of these resources are of limited benefit to patients…